TEMPLE, a Phase 3 multicenter, randomized, double-blind, head-to-head study, evaluated the tolerability, safety and efficacy of atogepant compared to topiramate for the preventive treatment of migraine in adult patients with a history of four or more migraine days per month
BRAVE study will explore the potential of omaveloxolone to address the critical unmet need of the pediatric FA population
The GMP-compliant facility with automated environmental monitoring accommodates both white room and class 7 and 8 cleanroom space
Sun Pharma gets 8 observations from USFDA for Halol facility
The company received one observation in the Form-483
Innovative agents highlight growth of targeted protein degradation platform and BMS' leadership in innovative cancer therapies
The companies aim to create customized AI models and agents that Novo Nordisk can use for early research and clinical development
The project will be instrumental in enhancing the company's API manufacturing capacity and global reach
Conceptulised by Lowe Lintas, the new campaign creatively brings the "fast action" benefit of Cipladine to life through a series of films
The company received 1 (One) observation in the Form-483
Subscribe To Our Newsletter & Stay Updated
